Defined Mesenchymal Stem Cell Culture Medium for Cartilage Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for deriving mesenchymal stem cells are inefficient and often use non-defined components like matrigel and fetal bovine serum, compromising clinical application, and adult-derived MSCs have limited lifespan and differentiation potential, making them unsuitable for effective cartilage repair.
Innovation Solution
A method involving culturing lateral plate mesoderm cells in a mesenchymal stem cell culture medium containing fibroblast growth factor, platelet-derived growth factor, epidermal growth factor, and ascorbic acid to generate mature mesenchymal stem cells, which can be used for cartilage and bone disease treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods use matrigel and fetal bovine serum for deriving mesenchymal stem cells, then cell derivation is possible, but the components are non-defined which compromises clinical application
Solution Approach 1:
The invention changes the chemical composition parameters of the culture medium by replacing non-defined components (matrigel, FBS) with defined alternatives including specific growth factors (bFGF, EGF, PDGF, TGF-beta), ascorbic acid, and other supplements at controlled concentrations, thereby achieving clinical-grade defined medium while maintaining cell derivation capability
Solution Approach 2:
The invention extracts and removes the non-defined components (matrigel, fetal bovine serum) from the culture medium formulation, replacing them with individually characterized and controlled defined components, thus eliminating the reliability issue while preserving the essential functions needed for MSC derivation
2Duration of action of moving object
If adult-derived mesenchymal stem cells are used for cartilage repair, then immediate treatment is possible, but they have limited lifespan and differentiation potential
Solution Approach 1:
The invention performs preliminary optimization of culture conditions with defined growth factors and supplements before actual cell expansion, establishing optimal parameters (bFGF, EGF, PDGF, TGF-beta concentrations) that pre-condition the cells for extended lifespan and maintained differentiation potential throughout the expansion process
Solution Approach 2:
The invention maintains continuous expression of differentiation potential and extended lifespan by providing sustained levels of essential growth factors and supplements throughout the culture period, ensuring that the cells continuously receive signals that preserve their functional capabilities rather than allowing degradation over time
3Quantity of substance
If articular chondrocytes are expanded in vitro for transplantation, then sufficient cell numbers are obtained, but the cells de-differentiate into fibroblasts
Solution Approach 1:
The invention changes the culture medium composition parameters by including specific concentrations of growth factors (bFGF, EGF, PDGF, TGF-beta) and supplements (ascorbic acid, insulin, transferrin) that maintain chondrocyte differentiation state while allowing expansion, preventing de-differentiation into fibroblasts
Solution Approach 2:
The invention introduces growth factors and signaling molecules as intermediary substances that mediate between the culture environment and the chondrocytes, maintaining their differentiated state through biochemical signaling while permitting proliferation, thus acting as a bridge that preserves cell identity during expansion
Data Source
AI summary
The present disclosure provides a method of generating mature mesenchymal stem cells and the cell culture medium used in such method. Also disclosed herein include a mesenchymal stem cell culture obtained by the method as disclosed herein, and uses thereof.